11.17.22
Safety net and rural hospitals—critical components of our public health system—face overwhelming challenges that have brought many to the brink of insolvency.
11.09.22
The 340B discount program—which requires manufacturers to provide outpatient drugs to eligible health care entities at sharply reduced prices—continues to be both controversial and confusing.
11.01.22
Strengthening our nation’s long-term care system is a pressing societal issue as growing numbers of older Americans and people living with disabilities or chronic diseases increase demand.
10.12.22
Although increasing representation of underserved populations in clinical trials has been a long-standing goal for industry, providers and patients alike, progress to date has been slow.
09.28.22
Americans are strongly focused on the upcoming midterm elections.
09.22.22
The Inflation Reduction Act of 2022 (IRA) includes the most dramatic change to U.S. drug price regulation in history.
09.08.22
In late June, California’s Governor Newsom signed the California Health Care Quality and Affordability Act, establishing a new Office of Health Care Affordability (OHCA) within the Department of Health Care Access and Information (HCAI).
08.02.22
The United States continues to face a behavioral health crisis that has worsened due to the COVID-19 pandemic. In 2021, nearly 40% of adults reported symptoms of depression or anxiety, an increase from 10% in 2019.
07.27.22
Last year, the number of overdose deaths in the United States exceeded 100,000 for the first time ever.
07.25.22
Mounting evidence indicates that addressing the social and economic factors that drive the majority of health outcomes, often called social drivers of health, can improve health, promote health equity and reduce costs.